Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT02936362 Completed - Clinical trials for Dietary Modification

Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals

Start date: February 2016
Phase: N/A
Study type: Interventional

Bread is the most common grain product in the world, with consumption surpassing 3 billion individuals per year. Sourdough whole-grain bread is considered a healthy alternative to white, refined-wheat bread. This cross-over study will test the effect of consumption of sourdough bread compared to white bread following a short dietary intervention period (one week) on multiple clinical parameters and gut microbiota.

NCT ID: NCT02935478 Suspended - Obesity Clinical Trials

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

Start date: October 18, 2017
Phase: N/A
Study type: Interventional

Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor and has a grave prognosis. Obesity is an epidemic in the US.Patients with HCC and obesity are not candidates for liver transplantation, depriving them of the best option for cure from HCC. Recent studies have shown that blocking blood vessels to a particular portion of the stomach (bariatric or left gastric artery embolization) can temporarily decrease levels of the appetite inducing hormone ghrelin, and result in weight loss.The purpose of this study is to determine if Left gastric artery embolization (LGAE) in patients with cirrhosis and HCC who are not transplant candidates due to morbid obesity, leads to clinically significant weight loss with eligibility for liver transplantation.

NCT ID: NCT02933554 Not yet recruiting - Obesity Clinical Trials

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

Start date: June 2024
Phase: N/A
Study type: Interventional

Obesity is an epidemic in the US. With progression of obesity, Nonalcoholic steatohepatitis (NASH) has been a growing public health issue. Presently there is no cure for NASH.Prevention of progression of fibrosis in NASH is crucial, as they are at a high risk for cirrhosis and may need liver transplant. Recent studies have shown that blocking blood vessels to a particular portion of the stomach (bariatric or left gastric artery embolization) can temporarily decrease levels of the appetite inducing hormone ghrelin, and result in weight loss.The purpose of this study is to determine if Left gastric artery embolization (LGAE) in patients with obesity and NASH leads to clinically significant weight loss with improvement of NASH.

NCT ID: NCT02932748 Completed - Obesity Clinical Trials

Weight Management in Rural Communities

M-DEx
Start date: January 2017
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the effect of three weight management interventions (group phone conference calls, individual phone calls, and enhanced usual care) on weight across 18 months in overweight and obese adults recruited through and treated by rural primary care clinics.

NCT ID: NCT02930928 Completed - Weight-Estimation Clinical Trials

Can Habitus Adapted Length Based Body Weight Estimation be Improved by Adding Further Parameters?

Including MUC
Start date: October 2016
Phase:
Study type: Observational

The purpose of this prospective single center study is to investigate if the accuracy of length based body weight estimation by the already investigated algorithm (CLAWAR) can be improved by adding another parameter. For this study 500 patients are required to collect anonymized data (length, weight, age, mid upperarm circumference and patient habitus by visual estimation) for achieving a power of 80% during statistical analysis. The main hypothesis ist that CLAWAR's accuracy can be improved.

NCT ID: NCT02930668 Completed - Clinical trials for Overweight and Obesity

Efficacy and Safety of Glucosanolâ„¢ in Body Weight Reduction

Start date: May 2016
Phase: N/A
Study type: Interventional

It was proven in a previous clinical study that Glucosanolâ„¢ is effective and safe in reducing weight in the overweight and obese. The present study aims at expanding the data concerning the weight management effect of Glucosanolâ„¢ in overweight and moderately obese population.

NCT ID: NCT02928653 Completed - Body Weight Clinical Trials

Beverage Consumption and Fine Motor Control

LCS
Start date: December 2015
Phase: N/A
Study type: Interventional

The aim of this study will be to compare the effects of daily consumption of aspartame, rebaudioside a, saccharin, sucralose, and sucrose on body weight and composition in a standardized protocol. The investigators hypothesize that individual low calorie sweeteners (consumed in a beverage) differ from each other in promoting weight loss and decreased fat mass (without energy restriction or dietary guidance) based on their chemical structure.

NCT ID: NCT02923882 Completed - Pregnant Women Clinical Trials

$100Kitchen and Low-birth-weight Study in Rural Bangladesh

Start date: April 2013
Phase: Phase 2
Study type: Interventional

Low-birth-weight (LBW) is a major adverse pregnancy outcome in resource-poor countries. About 28% of all neonatal deaths worldwide are directly attributed to LBW. Exposure to biomass fuel during cooking is associated with LBW. There is unlikely to be any significant change in the use of biomass fuels in the near future, therefore, interventions targeted to reduce the harmful effects on poor pregnancy outcomes is warranted. To address this need, the investigators proposed a locally-made inexpensive prefabricated model of the "100-dollar-kitchen"($100Kitchen) with an improved cookstove for resource-poor settings. The improved cookstove of the $100Kitchen ensure complete incineration of the biomass fuels and thus, provided safeguard to the pregnant women using these fuels. This study has been measured the impact of our '$100Kitchen and improved cookstove' intervention as to whether a pregnant woman residing in a household with a '$100Kitchen and improved cookstove' is less likely to give birth to a LBW newborn. A cluster-randomized controlled trial has been adopted in Shahjadpur sub-district in Bangladesh and 628 and 639 pregnant women at 8-12 weeks gestational age enrolled for each intervention and control area respectively and followed-up through 42-days post-delivery. Birth outcomes have been noted and the newborns have been weighted within 72-hrs of the delivery. Non-invasive maternal blood Carbon Monoxide Hemoglobin saturation (SpCO) level between the intervention and control groups have also been measured.

NCT ID: NCT02923674 Completed - Obesity Clinical Trials

Empowered With Movement to Prevent Obesity and Weight Regain

EMPOWER
Start date: December 6, 2016
Phase: N/A
Study type: Interventional

This study will help determine the appropriate type, amount and intensity of physical activity most beneficial for preventing weight regain after weight loss in older adults.

NCT ID: NCT02911337 Completed - Weight Loss Clinical Trials

Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction

WTLSSCHF
Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the efficacy of an intensive, supervised, lifestyle modification program on symptoms and signs of heart failure as well as laboratory and echocardiographic measures of cardiac structure and function. This will be a 6 month trial in 50 patients with a clinical diagnosis of heart failure with preserved ejection fraction (HFpEF). Patients will be enrolled in the Medical University of South Carolina weight management 15 week lifestyle change program which will involve weekly visits that rotate among the clinical specialities (dietary, exercise and behavioral) and scheduled visits with the research Registered Nurse. Each patients baseline data will be used as the control and compared with the same measurements at the 6 month end point.